Trial intelligence / Profile preview

Opioid Free Anesthesia in Bariatric Surgery

NCT04048200Phase 4Completed

Sponsor
Tanta University
Start
Sep 2019
Primary completion
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine and ketamine in class III obesity (2 arms), sponsored by Tanta University. Primary endpoint: Postoperative opioid consumption at 24 hours. Started Sep 2019; status: completed.

02

Drugs

dexmedetomidineketamine
03

Conditions

class III obesity

Beyond the preview

Go deeper on NCT04048200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04048200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call